Chinese herbal medicine fuzheng huayu recipe inhibits liver fibrosis by mediating the transforming growth factor-β1/ smads signaling pathway

Journal of Chinese Integrative Medicine

Volumn 10, Issue 5, 2012, Pages 561-568

  Wang, Qing Lan ^a,b   Tao, Yan Yan ^a   Shen, Li ^a   Cui, Hong Yan ^a   Liu, Cheng Hai ^a,b  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shanghai Key Laboratory of Traditional Chinese Clinical Medicine   (China)

Author keywords

Chinese herbal; Drugs; Hepatic stellate cell; Liver fibrosis; Rats; Receptor regulated; Smad proteins; Transforming growth factor betal

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CHINESE DRUG; COLLAGENASE; FUZHENG HUAYU; HERBACEOUS AGENT; HYDROXYPROLINE; LIVER PROTECTIVE AGENT; PRONASE; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA1 RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DOWN REGULATION; DRUG MECHANISM; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TEMPERATURE; LIVER FIBROSIS; LIVER PROTECTION; MALE; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; STELLATE CELL; WESTERN BLOTTING;

ANIMALS; DRUGS, CHINESE HERBAL; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PHYTOTHERAPY; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84861625846     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20120512     Document Type: Article

References (21)

1. Liu P, Liu C, Xu LM, Hu YY, Xue HM, Liu CH, Zhang ZQ. Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B. World J Gastroenterol. 1998; 4(4): 348-353.
2. Liu C, Hu Y, Xu L, Liu P. Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Chin Med. 2009; 4: 12.
3. Zhou T, Yan XC, Chen Q, Tao YY, Hu YY, Liu P, Liu CH. Effects of Chinese herbal medicine Fuzheng Huayu recipe and its components against hepatocyte apoptosis in mice with hepatic injury. J Chin Integr Med. 2011; 9(1): 57-63. Chinese with abstract in English.
4. Ji G, Liu P, Liu C, Xu LM, Hong JH. Effect of sera from the rats treated with Fuzheng Huayu (FZHY) decoction on rat hepatocyte proliferation and collagen synthesis in vitro. Zhongguo Shi Yan Fang Ji Xue Za Zhi. 1997; 3(3): 20-23. Chinese with abstract in Enlglish.
5. Moreira RK. Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med. 2007; 131(11): 1728-1734.
6. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-β in hepatic fibrosis. Front Biosci. 2002; 7: d793-d807.
7. Liu CH, Wang XL, Liu P, Liu C, Tan YZ, Gu HT. Serapharmacological effect of Fuzheng Huayu 319 Decoction on expression of type i collagen and transforming growth factor β1 in hepatic stellate cells. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1999; 19(7): 412-414. Chinese with abstract in English.
8. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type i activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2002; 62(1): 65-74.
9. Tao YY, Cui HY, Liu CH. Dynamic characteristics of SARA during liver fibrogenesis in rats. Zhonghua Gan Zang Bing Za Zhi. 2006; 14 (12): 909-913. Chinese with abstract in English.
10. Jamall IS, Finelli VN, Que Hee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem. 1981; 112(1): 7075.
11. Liu CH, Liu P, Liu C, Ji G, Xu LM. Study on a seropharmacological method for an effective antifibrotic formula. Zhongguo Shi Yan Fang Ji Xue Za Zhi. 1998; 4(2): 16-19. Chinese with abstract in English.
12. Zhao JF, Liu CH, Hu YY, Xu LM, Liu P, Liu C. Effect of salvianolic acid B on Smad3 expression in hepatic stellate cells. Hepatobiliary Pancreat Dis Int. 2004; 3(1): 102-105.
13. Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011; 6: 425-456.
14. Kawada N. Evolution of hepatic fibrosis research. Hepatol Res. 2011; 41(3): 199-208.
15. Galicia-Moreno M, Rodriguez-Rivera A, Reyes-Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P, Moreno MG, Muriel P. N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-β and oxidative stress. Eur J Gastroenterol Hepatol. 2009; 21(8): 908-914.
16. Ikushima H, Miyazono K. Biology of transforming growth factor-β signalin. Curr Pharm Biotechnol. 2011 May 27. [Epub ahead of print]
17. Zhao CQ, Wu YQ, Xu LM. Curative effects of Fuzheng Huayu capsules on hepatic fibrosis and the functional mechanisms: a review. J Chin Integr Med. 2006; 4(5): 467-472. Chinese with abstract in English.
18. Liu X, Hu H, Yin JQ. Therapeutic strategies against of Smads in activated cells is TGF-(Hndependent. J Biol TGF-β signaling pathway in hepatic fibrosis. Liver Int. 2006; 26(1): 8-22.
19. Liu C, Gaca MD, Swenson ES, Vellucci VF, Reiss M, Wells RG. Smads 2 and 3 are differentially activated by transforming growth factor-β (TGF-β) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-β-independent. J Biol Chem. 2003; 278(13): 11721-11728.
20. Hofman K, Hall B, Cleaver H, Marshall S. High-throughput quantification of hydroxyproline for determination of collagen. Anal Biochem. 2011; 417(2): 289-291.
21. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008; 88 (1): 125-172.